Prothena to Report First Quarter 2019 Financial Results on May 7
30 avr. 2019 16h05 HE
|
Prothena Corporation plc
DUBLIN, Ireland, April 30, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, will announce financial results for the first quarter of 2019 on...
Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
18 avr. 2019 16h05 HE
|
Prothena Corporation plc
Results from final analysis of the composite primary endpoint were consistent with the futility analysis reported in April 2018Results from post hoc analyses revealed a potential survival benefit with...
Prothena to Participate in Upcoming March Healthcare Conferences
05 mars 2019 16h05 HE
|
Prothena Corporation plc
DUBLIN, Ireland, March 05, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, today announced that members of its senior management team will...
Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update
14 févr. 2019 16h05 HE
|
Prothena Corporation plc
Net cash used in operating and investing activities was $22.5 million in the fourth quarter and $30.0 million for the full year 2018; quarter-end cash and restricted cash position of $431.7 million...
Prothena to Report Fourth Quarter and Full Year 2018 Financial Results and Host Webcast Conference Call on February 14
04 févr. 2019 16h05 HE
|
Prothena Corporation plc
DUBLIN, Ireland, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, announced today that it will report its fourth quarter and full year...
Prothena Reports Third Quarter 2018 Financial Results and Provides R&D Update
06 nov. 2018 16h05 HE
|
Prothena Corporation plc
Net cash used in operating and investing activities was $33.7 million in the third quarter and $7.5 million in the first nine months of 2018; quarter-end cash and restricted cash position of $455.6...
Prothena to Report Third Quarter 2018 Financial Results on November 6
30 oct. 2018 16h05 HE
|
Prothena Corporation plc
DUBLIN, Ireland, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the third quarter and first nine...
Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update
07 août 2018 16h05 HE
|
Prothena Corporation plc
Net loss was $59.9 million in the second quarter and $108.6 million for the first six months ended June 30, 2018Net cash from operating and investing activities was $58.0 million in the second quarter...
Prothena to Report Second Quarter 2018 Financial Results on August 7
31 juil. 2018 16h05 HE
|
Prothena Corporation plc
DUBLIN, Ireland, July 31, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the second quarter and first six...
Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer
25 juin 2018 16h05 HE
|
Prothena Corporation plc
DUBLIN, Ireland, June 25, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the...